The effect of COVID-19 disease on patients diagnosed with skin cancer in the dermatology clinic

Alper Alyanak 1, *, Nurhan Döner Aktaş 1, Büşra Emir 2, Türkan Güray 1 and Ayşe Yazıcı 3

1 Department of Dermatology, Izmir Katip Çelebi University, Medical Faculty, Atatürk Research and Education Hospital, Izmir, Turkey.
2 Department of Biostatistics, Izmir Katip Çelebi University Medical Faculty, Izmir, Turkey.
3 Department of Pathology, Izmir Katip Çelebi University, Medical Faculty, Atatürk Research and Education Hospital, Izmir, Turkey.
 
Research Article
World Journal of Advanced Research and Reviews, 2024, 22(01), 018–026
Article DOI: 10.30574/wjarr.2024.22.1.1006
Publication history: 
Received on 20 February 2024; revised on 27 March 2024; accepted on 30 March 2024
 
Abstract: 
Objective: We aimed to define the impact of the pandemic on patients presenting to dermatology clinic with skin cancer.
Methods: In our study, the characteristics of patients who attended our dermatology clinic before six months and after six months of March 11, 2020, and whose biopsies diagnosed as basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and malignant melanoma (MM) were evaluated and compared regarding before and after COVID-19 pandemic
Results: Patients with BCC attending to the dermatology clinic were found to be younger in the pandemic period (p<0.05). Gender, duration of skin tumors, primary lesions, and their locations were found to be not statistically significant (p>0.05).
Conclusion: Patients with suspicious skin lesions could be encouraged to visit a hospital with appropriate COVID-19 protection. Alternatively, teledermatology could be used to evaluate whether the lesions should be excised or biopsied.
 
Keywords: 
Skin cancer; COVID-19; Hospital application; Biopsy
 
Full text article in PDF: 
Share this